AUTL AUTOLUS THERAPEUTICS PLC
2026Q1 · CUSIP 05280R100 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
83
Δ holders QoQ
-6
Breadth percentile
Top 80%
Whale holders
37
Δ whales
0
Inst. holding value
$183M
New positions
9
Closed positions
15
Price momentum (1Q)
+19.2%
Put / Call
0/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 14% | -12.5% | -29.8% |
| 2023Q4 | Top 19% | -35.7% | -43.8% |
| 2019Q2 | Top 13% | +12.7% | +3.0% |
Options Sentiment
Put holders
0
QoQ: -1
Call holders
3
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.09
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
—
Net margin
-312.0%
ROE
-265.5%
Debt ratio
79.3%
FCF (TTM)
-$287M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.